Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis
Clinical trial NCT03768219 · TERMINATED
Trial details
- NCT number
- NCT03768219
- Sponsor
- Aptevo Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2020-06-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.